Problems with mold at a Sanofi ($SNY) plant that flooded last fall has forced the plant to close for remediation, setting the stage for a global shortage of the bladder cancer drug ImmuCyst.

Submit 'Mold may lead to Sanofi cancer drug shortage' to Twitter   Submit 'Mold may lead to Sanofi cancer drug shortage' to Facebook      

Leave a Comment



Discuss   Tell a friend   Bury Print Preview

Comments Who Voted Related Links